Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age

Name: Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age
License: Public Domain

BioNTech SE

ClinicalTrials.gov · Datasets · License: Public Domain

sars-cov-2 infection, covid-19

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 143662
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.